Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,251 | 33,093 | 35,735 | 30,031 | 32,887 |
| Other current assets | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $30,667 | $33,564 | $36,490 | $30,353 | $33,167 |
| Non-Current Assets | |||||
| PPE Net | 36 | 42 | 32 | 37 | 30 |
| Intangibles | 0 | 0 | 0 | 0 | 23 |
| Other Non-Current Assets | 33 | 33 | 33 | 33 | 33 |
| TOTAL | $69 | $75 | $65 | $70 | $86 |
| Total Assets | $30,736 | $33,639 | $36,555 | $30,423 | $33,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 317 | 178 | 189 | 335 | 365 |
| Accrued Expenses | 1,212 | 733 | 638 | 861 | 1,023 |
| TOTAL | $1,698 | $1,166 | $1,029 | $1,419 | $1,674 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,698 | $1,166 | $1,029 | $1,419 | $1,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,545 | 26,545 | 26,545 | 26,545 | 20,706 |
| Common Shares | 265 | 265 | 265 | 207 | 207 |
| Retained earnings | -260,843 | -257,251 | -253,927 | -251,155 | -248,517 |
| TOTAL | $29,038 | $32,473 | $35,526 | $29,004 | $31,579 |
| Total Liabilities And Equity | $30,736 | $33,639 | $36,555 | $30,423 | $33,253 |